Actively Recruiting
2% Lidocaine Gel in Reducing Postoperative Pain Following Haemorrhoidectomy
Led by E-DA Hospital · Updated on 2024-06-12
400
Participants Needed
1
Research Sites
74 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is a randomized, double-blind, controlled trial evaluating the efficacy of 2% lidocaine gel in reducing postoperative pain and analgesic consumption after haemorrhoidectomy. 222 patients undergoing Ferguson haemorrhoidectomy will be randomly assigned to receive either 2% lidocaine gel or a non-anaesthetic lubricant gel control. Pain scores using a visual analog scale (VAS) will be assessed at 12 and 24 hours, and 2, 3, and 7 days postoperatively. Analgesic consumption will also be measured.
CONDITIONS
Official Title
2% Lidocaine Gel in Reducing Postoperative Pain Following Haemorrhoidectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosed with Grade III or IV hemorrhoids
- Candidate for Ferguson haemorrhoidectomy
You will not qualify if you...
- Not a candidate for Ferguson haemorrhoidectomy
- Recurrent hemorrhoidal disease
- Concurrent anal pathology diagnosed preoperatively, including anal fistula, anal fissure, or anal polyp
- History of diabetes mellitus
- History of liver cirrhosis
- History of inflammatory bowel disease
- Documented neuropathy
- Coagulation disorders
- Currently on anticoagulants
- Documented allergy to any of the drugs included in the protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
E-Da hospital
Kaohsiung City, Taiwan, 812
Actively Recruiting
Research Team
C
Chen Chih-i
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here